Pricing Log in Create free account

Inhibrx Biosciences, Inc. (INBX) vs Seaport Therapeutics, Inc (SPTX)

Inhibrx Biosciences, Inc. and Seaport Therapeutics, Inc are both Biotechnology companies. Inhibrx Biosciences, Inc. and Seaport Therapeutics, Inc are of similar size ($1.2B and $1.1B). Across the 9 metrics below, Seaport Therapeutics, Inc leads on 5 and Inhibrx Biosciences, Inc. on 4.

Valuation

Metric INBX SPTX Biotechnology median
P/E n/m n/m 10.60
P/S 424.97 n/m 9.40
P/B n/m 2.85 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 438.60 n/m 9.02
Earnings yield (10.39%) (107.07%) (32.88%)
Free cash flow yield (9.85%) (8.47%) (23.13%)

Profitability

Metric INBX SPTX Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (1,773.60%) (74.36%) (51.96%)
Return on assets (75.44%) (37.78%) (46.06%)
Return on invested capital 0.00% (88.12%) 0.00%

Growth

Metric INBX SPTX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (108.03%) 36.55% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric INBX SPTX Biotechnology median
Debt to equity (3.33) 0.00 0.00
Current ratio 5.07 17.48 4.97
Net debt to EBITDA 0.18 2.42 1.01

Dividend

Metric INBX SPTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric INBX SPTX Biotechnology median
Market cap 1.18b 1.09b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack